The FDA’s crackdown on deceptive drug advertising is having a negative impact on pharma advertising across multiscreen TV platforms, the VAB notes. But, that has resulted in a boost for broadcast television, as has been seen in Media Monitors Spot Ten National TV reports shared by RBR+TVBR over the last several months.
The VAB now finds that pharma’s TV spend has increased significantly, with dollars shifting from the digital realm.
